As a practicing physician and surgeon, I recommend you online pharmacies sponsor my blog:

« COMPLICATIONS OF PARENTERAL NUTRITION
Insensible Water Losses »


FETAL SURGERY: EVALUATION

Posted by Surgery on Sep 10, 2008
Based on the knowledge gained from the advances in the aforementioned diagnostic modalities, perinatal management recommendations have been formulated for select fetuses with life-threatening anomalies (Table 3-1). More precisely, the natural history, pathophysiology, associated anomalies, and therapeutic options have become the basis for the multidisciplinary fetal treatment team, which has enabled the approach to the fetus as patient (13:). Prenatal intervention has, in large part, been predicated on those anomalies that result in either low- or high-output cardiac failure resulting in hydrops (skin and/or nuchal edema or fluid accumulation in two of three body cavities (pleura, pericardium, peritoneum)]. Hydrops resulting from a specific lesion results in nearly 100% fetal mortality. Examples include fetuses with hydrops from a CCAM, sacrococcygeal teratoma (SCT:), pericardial teratoma, select heart defects, tension hydrothorax, twin–twin transfusion syndrome (TTTS:), and twin reversed arterial perfusion (TRAP) sequence. Pulmonary and kidney failure can be predicted in a subset of fetuses with urinary tract obstruction (e.g., posterior urethral valves:) and may benefit from US-guided vesicoamniotic shunt placement.
, , Scientific Principles, The Fetus as a Patient, FETAL
Select fetuses with threatened postnatal airway obstruction from a cervical teratoma or lymphangioma may benefit from the ex utero intrapartum treatment (EXIT:) strategy in which a cesarean delivery approach is used, but myometrial bleeding is controlled and the umbilical cord is not cut until an airway is obtained—by orotracheal intubation, tracheostomy, or mass resection followed by intubation or tracheostomy. Selective reduction for complications of monochorionic twinning has been used with increasing frequency given the low relative risk and ease of the procedure. Presently, a percutaneous, needle-based, US-guided approach using radiofrequency energy can perform this procedure under local anesthesia in under 5 minutes. Controversial areas of maternal–fetal intervention include nonlethal anomalies such as laser therapy for amniotic band syndrome and prenatal repair of a myelomeningocele. There are a host of nonlethal fetal anomalies whose outcomes are enhanced by prenatal diagnosis and counseling since the timing, mode, and venue of delivery are often important variables that directly affect postnatal outcome. Examples include hydrocephalus, gastroschisis, omphalocele, and urinary tract obstruction.
The prerequisites for consideration of maternal fetal intervention for specific anomalies include (1) an accurate prenatal diagnosis; (2) the absence of severe associated anomalies; (3:) a well-defined natural history; (4) the presence of a correctable lesion that, if uncorrected, will lead to fetal death or irreversible organ dysfunction before birth; and (5) technical feasibility of repair. Specific inclusion/exclusion criteria developed at multiple centers for maternal–fetal are listed in Table 3-2.
Upon referral to a fetal treatment program, potential patients undergo an evaluation that includes a comprehensive ultrasonographic assessment of the identified lesion and a screen for associated anomalies. If indicated, fetal ultrafast MRI can be performed to gain greater anatomic detail for those lesions with persistent vagaries that may impact final recommendations. All fetuses are evaluated by echocardiography to rule out concomitant congenital cardiac disease, which might preclude any fetal intervention when in association with a second anomaly. All patients undergo genetic screening via one of the sampling techniques discussed previously. Findings of any chromosomal abnormalities, multiple structural anomalies, or a multiple gestation (other than twinning-associated anomalies) all preclude further consideration for fetal (14,15:). Finally, the maternal social support structure and other maternal comorbidities are heavily considered.
, , Scientific Principles, The Fetus as a Patient, FETAL

Related Posts on this articles....

Tags: , , ,
Leave a Reply

You must be logged in to post a comment.